REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Polbionica Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Other Industrial Machinery Manufacturing | Merchant Wholesalers, Durable Goods | Retail Trade | Other Information Services | Rental and Leasing Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Polbionica Sp. z o.o. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Polbionica Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was incorporated on August 22, 2019. From the latest financial highlights, Polbionica Sp. z o.o. reported a net sales revenue increase of 145.9% in 2023. There was a total growth of 88.39% in Polbionica Sp. z o.o.’s total assets over the same period. Polbionica Sp. z o.o.’s net profit margin increased by 144.81% in 2023.

Headquarters
Ul. Aleja Prymasa Tysiaclecia 79A
Warsaw; Mazowieckie; Postal Code: 01-242

Contact Details: Purchase the Polbionica Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Polbionica Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Polbionica Sp. z o.o. report to view the information.
Incorporation Date:
August 22, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
43.43%
Purchase this report to view the information.
20.99%
Purchase this report to view the information.
14.23%
Company Performance
Financial values in the chart are available after Polbionica Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
145.9%▲
Total operating revenue
-15.12%▼
Operating profit (EBIT)
49.59%▲
EBITDA
94.63%▲
Net Profit (Loss) for the Period
37.82%▲
Total assets
88.39%▲
Total equity
19.04%▲
Operating Profit Margin (ROS)
153.74%▲
Net Profit Margin
144.81%▲
Return on Equity (ROE)
28.35%▲
Debt to Equity Ratio
114.09%▲
Quick Ratio
-1.46%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
Polpharma Biologics S.A.
 
Ryvu Therapeutics S.A.
Slaski Park Technologii Medycznych Kardio-Med Silesia Sp. z o.o.
 
Europejskie Centrum Sekwencjonowania Sp. z o.o.
Qsar Lab Sp. z o.o.
 
Explorna Therapeutics Sp. z o.o.
Bioresearch Group Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo